New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
September 29, 2010
11:16 EDTLLY, BCSI, WDC, CSTR, MNKD, DELLOn The Fly: Rumor Buzz
Market speculation today includes takeover chatter involving Coinstar (CSTR)...Blue Coat Systems (BCSI) advances about 4.9% and is again the subject of an unconfirmed takeover rumor. Dell (DELL) has previously been mentioned as a possible suitor...Western Digital Corp. (WDC) is up almost 3.5% on renewed takeover speculation...Unconfirmed is a rumor that Eli Lilly & Co. (LLY) is readying a $12.50 bid for MannKind Corp. (MNKD), up 2.9%.
News For CSTR;BCSI;DELL;WDC;LLY;MNKD From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
December 19, 2014
09:48 EDTLLYBiogen should be bought on weakness after Roche drug halted, says Evercore ISI
Subscribe for More Information
08:53 EDTLLYBiogen drug, trial differs from Roche Alzheimer's drug, says RBC Capital
Subscribe for More Information
05:39 EDTLLYEli Lilly, Adocia to co-develop BioChaperone Lispro
Subscribe for More Information
December 17, 2014
10:14 EDTWDCHP best way to play coming PC sales outperformance, Citi says
Sales of PCs will be at least flat next year, before growing slightly in 2016 and 2017, Citigroup wrote in a note to investors today. The firm identified HP (HPQ) as the best way to play better than expected PC sales. WHAT'S NEW: Although many believe that PCs will become extinct, there are several reasons why sales of personal computers will begin growing again, Citi analyst Jim Suva contended. Sales of commercial PCs in emerging markets should increase over the long-term, as those PCs are aging, according to Suva. He estimated that commercial PCs in emerging markets account for 27% of the total PC market. Meanwhile, tablets were supposed to replace PCs, but tablet sales growth slowed to just 8% this year, indicating that tablets are becoming less of a threat to PCs, he wrote. Additionally, some believe that PC demand was inflated by a rush to replace computers running Microsoft's (MSFT) Windows XP operating system this year after the company stopped supporting XP, but Suva believe that PC demand growth in 2014 was more driven by a need to buy new computers following a lull in growth in 2012-2013 than by the XP situation. As a result, the analyst estimates that the XP phenomenon will only reduce next year's PC growth by 1%, versus the 3%+ reduction that investors fear. HP is the best way to play the PC rebound, wrote Suva, who raised his price target on the company's shares to $46 from $40 and kept a Buy rating on the stock. WHAT'S NOTABLE: Suva raised his price target on hard disk drive maker Western Digital (WDX) to $125 from $110 and on its competitor, Seagate (STX), to $74 from $70, as he noted that the companies obtain about 50% of their revenue from PCs. He kept Buy ratings on both names. PRICE ACTION: In early trading, Hewlett-Packard gained 2.7% to $38.32, Western Digital rose 1.7% to $106.30, and Seagate climbed 1% to $63.89.
06:25 EDTWDCWestern Digital price target raised to $125 from $110 at Citigroup
Citigroup raised its price target for Western Digital (WDC) shares to $125 on expectations PCs will return to positive growth in 2016-2017. Citi believes Western Digital will benefit if its thesis on PCs proves correct. It also raised its price target for Seagate (STX) shares to $74 from $70. Citi keeps a Buy rating on both stocks.
December 16, 2014
14:48 EDTLLYEli Lilly's CYRAMZA receives third FDA approval
Subscribe for More Information
08:09 EDTWDCWestern Digital story remains under-appreciated, says Brean Capital
Brean Capital believes the enterprise value/free cash flow valuation for Western Digital remains under-appreciated. The firm sees an improving product mix and ongoing margin expansion and believes the company's acquisition of Skyera is a positive. Brean Capital reiterated its Buy rating and $125 price target on Western Digital shares.
December 15, 2014
16:33 EDTLLYEli Lilly raises quarterly dividend 2% to 50c per share
Subscribe for More Information
08:56 EDTWDCWestern Digital announces HGST to acquire Skyera
Subscribe for More Information
December 12, 2014
12:52 EDTLLYEli Lilly: FDA expands approved use of Cyramza to treat lung cancer
Subscribe for More Information
08:01 EDTMNKDPiper predicts two large-cap biotechs could be acquired in 2015
Subscribe for More Information
December 11, 2014
10:13 EDTLLYOn The Fly: Analyst Upgrade Summary
Subscribe for More Information
08:40 EDTLLYEli Lilly upgraded at Morgan Stanley
As previously reported, Morgan Stanley upgraded Eli Lilly two notches to Overweight from Underweight. The firm has increased confidence in Eli Lilly's pipeline investments following recent external data in Alzheimer's and atherosclerosis and now expects potential evacetrapib peak sales of $3B and solanezumab peak sales of $10B. Price target raised to $85 from $60.
06:22 EDTLLYEli Lilly upgraded to Overweight from Underweight at Morgan Stanley
Subscribe for More Information
December 10, 2014
08:09 EDTWDCWestern Digital price target raised to $129 from $124 at Jefferies
Subscribe for More Information
December 9, 2014
07:44 EDTLLYAmerican Association for Cancer Research to hold a symposium
Subscribe for More Information
07:11 EDTLLYEli Lilly and Incyte announce Phase 3 RA-BEACON study met primary endpoint
Subscribe for More Information
07:07 EDTWDCWestern Digital resolves two non-compliance matters with MOFCOM
Subscribe for More Information
December 8, 2014
08:10 EDTLLYLilly, Anthem, HealthCore form five-year research collaboration
Eli Lilly and Company (LLY), Anthem (ANTM) and HealthCore, Inc. announced that they have formed a five-year, real-world evidence research collaboration intended to improve health outcomes for patients. The companies will jointly develop and conduct research projects in health outcomes and real-world evidence in areas of mutual interest. Each party will bring distinct and valuable contributions to the collaboration, including the U.S. provider and patient environment, research capabilities, therapeutics and methods expertise, and integrated, researchable data. The collaboration allows the organizations to explore research opportunities across disease states and incorporate surveys and other information from providers and patients.
05:50 EDTMNKDStocks with implied volatility movement; AVNR MNKD
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use